HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Previous close
₹1,946.20
Day range
₹1,933.00 - ₹1,965.90
Year range
₹1,275.50 - ₹2,284.80
Market cap
547.13B INR
Avg Volume
998.54K
P/E ratio
54.19
Dividend yield
0.19%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 60.47B | 76.10% |
Operating expense | 25.64B | 36.23% |
Net income | 6.10B | 72.31% |
Net profit margin | 10.09 | -2.23% |
Earnings per share | — | — |
EBITDA | 23.54B | 291.88% |
Effective tax rate | 36.90% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.90B | 47.80% |
Total assets | 190.02B | 24.72% |
Total liabilities | 94.20B | 38.74% |
Total equity | 95.82B | — |
Shares outstanding | 282.18M | — |
Price to book | 5.73 | — |
Return on assets | — | — |
Return on capital | 50.13% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 6.10B | 72.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Founded
Nov 18, 1977
Website
Employees
15,800
